Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway
- Reference:
- Bioscience Reports
- 2020
- 40
- BSR20192826
- DOI:
- 10.1042/BSR20192826